ThinkGenetic Blog

News from ThinkGenetic

  • Home
  • SymptomMatcher
  • Disease Knowledge Base
  • News
  • About Us
  • Contact Us
Browse Diseases

ThinkGenetic Partners with ACD in Advocacy of People with Under-Recognized Genetic Metabolic Conditions

October 2, 2017 Len Barker Leave a Comment

Committed to providing resources to individuals about genetic diseases that is informed by patients and families, ThinkGenetic has teamed up with an organization dedicated to the three cerebral creatine deficiency syndromes (CCDS), the Association for Creatine Deficiencies (ACD).

By joining the two organizations in ThinkGenetic’s Advocacy Partner Program, ThinkGenetic and the ACD will work together to boost awareness of CCDS via the complimentary resources available from both organizations. In addition, supporters of the ACD can register at ThinkGenetic.com and earn ThinkPointsTM, which convert into a monetary donation from ThinkGenetic directly to ACD.

CCDS, such as guanidinoacetate methyltransferase deficiency (or GAMT), are inherited metabolic conditions that interrupt the creation or movement of creatine in the body. The body needs creatine to provide energy to all cells in the body, especially for cells in the muscles and brain. People with CCDS can have a range of symptoms and are frequently misdiagnosed as having cerebral palsy, autism, or developmental delay in infancy to childhood. As such, CCDS may be under-recognized.

Len Barker, President, ThinkGenetic, Inc“We are fortunate to have such a passionate group of CCDS advocates as partners,” said ThinkGenetic President Len Barker. “Combining our genetics expertise and worldwide reach with their intimate knowledge of living with CCDS, we are able to help more people seeking answers to questions about living with these disorders.”  

The ACD was established to raise awareness and education of CCDS among the medical community, as well as the public, and to advocate on behalf of families and patients living with CCDS.

“We are excited to be partnered with ThinkGenetic. This opportunity gives greater aid for CCDS patients and families who are searching for additional answers to their genetic disorder,” added Whitnie Strauss, President of the Association for Creatine Deficiencies.

Together, ThinkGenetic and ACD hope to enrich the lives of the families effected by CCDS through partnership.

About the ThinkGenetic Advocacy Partner Program: ThinkGenetic enters into Advocacy Partner agreements with organizations, support groups and charities to share information, increase public awareness of genetic conditions and provide trustworthy resources to those living with or caring for someone with a genetic disorder. Email advocacy@thinkgenetic.com to become an Advocacy Partner and visit news.thinkgenetic.com/advocacy-partner-program to see our current listing of Advocacy Partners.

Filed Under: Partners Tagged With: ACD, advocacy partners, Association for Creatine Deficiencies, CCD, GAMT, genetic conditions, Guanidinoacetate methyltransferase deficiency, Len Barker, metabolic conditions, ThinkGenetic, Whitnie Strauss

About Len Barker

Prior to co-founding ThinkGenetic with long time business partner, Dave Jacob, Len founded series of IT companies that focused on custom application development, education and advanced search technologies. He holds an Electrical Engineering degree from the United States Naval Academy, an MBA from Auburn University and is a licensed professional engineer.

Join the Conversation Cancel reply

Your email address will not be published. Required fields are marked *

Search the News & Press

Connect with Us

     
  • Home
  • News
  • About Us
  • Contact Us
  • Sponsor / Advertise
  • Disclaimers
  • Terms and Conditions
  • Privacy Policy
©2021 ThinkGenetic. All Rights Reserved.ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

Copyright © 2021 · Genesis Framework · WordPress · Log in